F · Healthcare
Drug Manufacturers - Specialty & Generic
GRAND PHARM. GRP. HD-01 (MX6A) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-30, reported market cap is $2.63B, P/E ratio is 10.36, net margin is 10.1%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
GRAND PHARM. GRP. HD-01 (MX6A) has a reported market cap of $2.63B (data as of 2026-03-30).
The price-to-earnings (P/E) ratio for GRAND PHARM. GRP. HD-01 (MX6A) is 10.36 (data as of 2026-03-30).
Dividend yield is not available in the current snapshot for GRAND PHARM. GRP. HD-01 (MX6A). Check the MyAverix Finance app for the latest dividend data.
GRAND PHARM. GRP. HD-01 (MX6A) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
MX6A is listed on F.
GRAND PHARM. GRP. HD-01 (MX6A) reports a net margin of 10.1% (data as of 2026-03-30).
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.